Will an FDA crackdown curb access to cheaper GLP-1 weight-loss drugs? Here’s what to know.
The Food and Drug Administration has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in “inordinate amounts.” The letter to Empower Pharmacy marks the first time the FDA has waded into a fierce debate about when a pharmacy’s legitimate work of customizing a medication crosses the…